Nabriva Therapeutics recruit new COO
July 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical
Nabriva Therapeutics, a pharmaceutical company that is developing new antibiotics for the treatment of serious infections, has brought Francesco Maria …
Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm
July 12, 2017Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals
Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …
Stada takeover back in motion after revised bid
July 12, 2017Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical
Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …
Contaminated blood inquiry to probe thousands of deaths
July 12, 2017Medical Communications, Research and Development HCV, HIV, biotech, drugs, haemophilia, pharma, pharmaceutical
UK Government has announced that it will launch an inquiry to discover how 4,670 people were given blood infected by …
Investigational drug found to boost treatment efficacy in paediatric brain cancer
July 12, 2017Research and Development AT/RT, Cancer, DIPG, TAK228, biotech, drugs, pharma, pharmaceutical
Researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, US, have revealed in a report …
Plot twist as FDA U-turns on Amicus drug decision
July 11, 2017Research and Development, Sales and Marketing Amicus Therapeutics, FDA, Galafold
The news continues to flow out of the FDA, as it grabs another headline by backtracking on its previous decision …
Sanofi snatches up Protein Sciences for $750 million
July 11, 2017Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, acquisition, protein sciences
French drug maker Sanofi has announced that it has agreed to acquire vaccine biotech company Protein Sciences for a potential …
Hope in quest for gonorrhoea vaccination
July 11, 2017Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination
Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …
Ipsen secures NICE approval for multi-targeting kidney cancer therapy
July 11, 2017Manufacturing and Production, Sales and Marketing Cabometyx, Kidney cancer, NICE
Ipsen has announced that its therapy Cabometyx (cabozantinib) has been given approval by NICE for the treatment of advanced renal …
ABPI launches legal action to overturn £20m price cap
July 11, 2017Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE
When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …
Brain tumours to be used to manufacture stem cells
July 10, 2017Manufacturing and Production, Research and Development Censo Biotechnologies, University of Leeds
Censo Biotechnologies has announced that it will collaborate with the University of Leeds to use the latest stem cell technology …
New director of CDC courts controversy from all angles
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US
It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …
Revealing the missing evidence: Randomised real-life studies in basal insulin therapy
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data
Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …
Endo withdraws product as FDA secures step in opioid crisis fightback
July 10, 2017Sales and Marketing Endo pharmaceuticals, FDA, Opana ER
The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the …
Problematic facility inspection puts Biocon’s biosimilar EU approvals on hold
July 10, 2017Manufacturing and Production, Sales and Marketing Biocon, India, biosimilars
Indian firm Biocon has been hit by regulator criticism which has forced its European biosimilar programme on hold following a …
Shire and Roche haemophilia spat spills into court
July 10, 2017Sales and Marketing Roche, Shire, haemophilia
Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …
European pharma pulls together to ensure ‘minimal disruption’ from Brexit
July 10, 2017Research and Development, Sales and Marketing EMA, Europe, UK
As a consequence of the triggering of Article 50 and the UK’s exit from the EU, the EMA – currently …
FDA gives go-ahead to first sickle cell treatment in 20 years
July 10, 2017Sales and Marketing Emmaus Medical, L-glutamine, sickle cell disease
Emmaus Medical has been handed approval for the first new treatment for sickle cell disease in two decades. The active …
AstraZeneca appoint new MD for India
July 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India
AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …
Oral sex creating super-gonorrhoea
July 7, 2017Research and Development antibiotic resistance, gonorrhoea
The WHO has announced that data from across 77 different countries show that the sexually-transmitted infection (STI) gonorrhoea is becoming …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
